Clinical Trials in Zhumadian, China
Locations / Zhumadian, China
Delta Trials records 69 clinical trials conducted in Zhumadian, China, making it a notable site of clinical research activity. These trials across 66 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 3 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Zhumadian has changed over time.
69
Total Trials
66
Conditions
3
Terminated since 2020
Browse by condition (66 total)
- Schizophrenia 6 trialsAll Schizophrenia trials
- Acute ischemic stroke 6 trialsAll Acute ischemic stroke trials
- Ischemic stroke, acute 4 trialsAll Ischemic stroke, acute trials
- Ischemic stroke 4 trialsAll Ischemic stroke trials
- Transient ischemic attack 3 trialsAll Transient ischemic attack trials
- Stroke 2 trialsAll Stroke trials
- All St segment elevation myocardial infarction trials
- H7n9 influenza 2 trialsAll H7n9 influenza trials
- Major depressive disorder 2 trialsAll Major depressive disorder trials
- Chronic hepatitis b 2 trialsAll Chronic hepatitis b trials
- Atrial fibrillation 2 trialsAll Atrial fibrillation trials
- Endovascular treatment 2 trialsAll Endovascular treatment trials
- Varicella 2 trialsAll Varicella trials
- T2dm (type 2 diabetes mellitus) 2 trialsAll T2dm (type 2 diabetes mellitus) trials
- Environmental exposures 1 trialAll Environmental exposures trials
- Minor stroke 1 trialAll Minor stroke trials
- Basilar artery occlusion 1 trialAll Basilar artery occlusion trials
- Insomnia disorder 1 trialAll Insomnia disorder trials
- Depression 1 trialAll Depression trials
- Stroke, ischemic 1 trialAll Stroke, ischemic trials